Följ
Velmurugu Yogambigai
Velmurugu Yogambigai
NYU School of Medicine
Verifierad e-postadress på nyulangone.org
Titel
Citeras av
Citeras av
År
Kinetic gating mechanism of DNA damage recognition by Rad4/XPC
X Chen, Y Velmurugu, G Zheng, B Park, Y Shim, Y Kim, L Liu, ...
Nature communications 6 (1), 5849, 2015
1052015
Twist-open mechanism of DNA damage recognition by the Rad4/XPC nucleotide excision repair complex
Y Velmurugu, X Chen, P Slogoff Sevilla, JH Min, A Ansari
Proceedings of the National Academy of Sciences 113 (16), E2296-E2305, 2016
642016
A voltammetry study on the diffusion of counter ions in polypyrrole films
MA Careem, Y Velmurugu, S Skaarup, K West
Journal of power sources 159 (1), 210-214, 2006
472006
Exploring the energy landscape of nucleic acid hairpins using laser temperature-jump and microfluidic mixing
R Narayanan, L Zhu, Y Velmurugu, J Roca, SV Kuznetsov, G Prehna, ...
Journal of the American Chemical Society 134 (46), 18952-18963, 2012
432012
Mapping the transition state for DNA bending by IHF
P Vivas, Y Velmurugu, SV Kuznetsov, PA Rice, A Ansari
Journal of molecular biology 418 (5), 300-315, 2012
342012
Ion and solvent transport in polypyrrole: experimental test of osmotic model
Y Velmurugu, S Skaarup
Ionics 11, 370-374, 2005
292005
Electronic Conductivity of Polypyrrole− Dodecyl Benzene Sulfonate Complexes
K West, L Bay, MM Nielsen, Y Velmurugu, S Skaarup
The Journal of Physical Chemistry B 108 (39), 15001-15008, 2004
262004
Monovalent ions modulate the flux through multiple folding pathways of an RNA pseudoknot
J Roca, N Hori, S Baral, Y Velmurugu, R Narayanan, P Narayanan, ...
Proceedings of the National Academy of Sciences 115 (31), E7313-E7322, 2018
242018
Fast folding of RNA pseudoknots initiated by laser temperature-jump
R Narayanan, Y Velmurugu, SV Kuznetsov, A Ansari
Journal of the American Chemical Society 133 (46), 18767-18774, 2011
242011
Cellular and humoral immunity to SARS‐CoV‐2 infection in multiple sclerosis patients on ocrelizumab and other disease‐modifying therapies: a multi‐ethnic observational study
I Kister, Y Patskovsky, R Curtin, J Pei, K Perdomo, Z Rimler, I Voloshyna, ...
Annals of Neurology 91 (6), 782-795, 2022
222022
Two-step interrogation then recognition of DNA binding site by Integration Host Factor: an architectural DNA-bending protein
Y Velmurugu, P Vivas, M Connolly, SV Kuznetsov, PA Rice, A Ansari
Nucleic acids research 46 (4), 1741-1755, 2018
202018
Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies
I Kister, R Curtin, J Pei, K Perdomo, TE Bacon, I Voloshyna, J Kim, ...
Annals of Clinical and Translational Neurology 9 (10), 1643-1659, 2022
112022
Slogoff Sevilla P., Min JH, Ansari A
Y Velmurugu, X Chen
Twist-open mechanism of DNA damage recognition by the Rad4/XPC nucleotide …, 2016
102016
Global analysis of ion dependence unveils hidden steps in DNA binding and bending by integration host factor
P Vivas, Y Velmurugu, SV Kuznetsov, PA Rice, A Ansari
The Journal of Chemical Physics 139 (12), 2013
92013
Dynamics and mechanism of DNA-bending proteins in binding site recognition
Y Velmurugu
Springer, 2016
62016
Antibody and T-cell responses to SARS-CoV-2 vaccines in MS patients on Ocrelizumab and other disease-modifying therapies: Preliminary results of an ongoing, prospective study
I Kister, Y Patskovsky, I Voloshyna, N Ferstler, R Curtin, V Yogambigai, ...
Multiple Sclerosis Journal, 755-756, 2021
12021
Longitudinal study of immunity to SARS-CoV2 in Ocrelizumab-treated multiple sclerosis patients up to 2 years after COVID-19 vaccination
I Kister, R Curtin, AL Piquet, T Borko, J Pei, BL Banbury, TE Bacon, A Kim, ...
medRxiv, 2024.01. 23.24301671, 2024
2024
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies (vol 10, pg1643, 2022)
I Kister, R Curtin, J Pei, K Perdomo, TE Bacon, I Voloshyna, J Kim, ...
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2023
2023
Humoral and Cellular Responses to SARS-CoV-2 Vaccines in MS Patients on Ocrelizumab and Other Disease-modifying Therapies: A Prospective Study From NYU Multiple Sclerosis Care …
I Kister, Y Patskovsky, R Curtin, I Voloshyna, K Perdomo, Z Rimler, J Pei, ...
Neurology 98 (18 Supplement), 2022
2022
Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies (preprint)
I Kister, R Curtin, J Pei, K Perdomo, TE Bacon, I Voloshyna, J Kim, ...
2022
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20